SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-24-033604
Filing Date
2024-04-17
Accepted
2024-04-17 09:17:25
Documents
17

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO FORM S-1 ea0203854-s1a5_allarity.htm   iXBRL S-1/A 883350
6 GRAPHIC img_001.jpg GRAPHIC 9072
7 GRAPHIC img_002.jpg GRAPHIC 9072
  Complete submission text file 0001213900-24-033604.txt   1172429

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE allr-20231231.xsd EX-101.SCH 3260
3 XBRL DEFINITION FILE allr-20231231_def.xml EX-101.DEF 6185
4 XBRL LABEL FILE allr-20231231_lab.xml EX-101.LAB 9521
5 XBRL PRESENTATION FILE allr-20231231_pre.xml EX-101.PRE 6055
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0203854-s1a5_allarity_htm.xml XML 1582
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-275224 | Film No.: 24849480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)